At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02005 SSY GROUP
Closed 01-20 16:08:04
2.970
+0.020
+0.68%
High2.980Low2.940Vol2.62M
Open2.980D1 Closing2.950Amplitude1.36%
Mkt Cap8.61BTradable Cap8.61BTotal Shares2.90B
T/O7.74MT/O Rate0.09%Tradable Shares2.90B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Zhutong Hong Kong Stock Shareholder Equity Disclosures | January 12
Stock News  ·  01-12
Zhutong Hong Kong Stock Shareholder Equity Disclosures | January 12
SSY GROUP Spends HK$1.3887 Million to Repurchase 456,000 Shares on January 9
Deep News  ·  01-11
SSY GROUP Spends HK$1.3887 Million to Repurchase 456,000 Shares on January 9
Why SSY Group (SEHK:2005) Is Up 6.6% After NMPA Clears New Hypertension Combo Therapy
Simply Wall St.  ·  01-09
Why SSY Group (SEHK:2005) Is Up 6.6% After NMPA Clears New Hypertension Combo Therapy
SSY GROUP (02005) Spends HK$1.3887 Million on January 9 to Repurchase 456,000 Shares
Stock News  ·  01-09
SSY GROUP (02005) Spends HK$1.3887 Million on January 9 to Repurchase 456,000 Shares
Hong Kong Stock Buyback Report | January 9
Stock News  ·  01-09
Hong Kong Stock Buyback Report | January 9
SSY Group Files Disclosure with HKEX on Repurchase of 1.49 Million Shares at HKD 3.03–3.05 Each
Reuters  ·  01-08
SSY Group Files Disclosure with HKEX on Repurchase of 1.49 Million Shares at HKD 3.03–3.05 Each
Zhitoing HK Shareholder Equity Disclosures | January 8
Stock News  ·  01-08
Zhitoing HK Shareholder Equity Disclosures | January 8
SSY Group (02005) Repurchases 1.5 Million Shares for HK$4.4694 Million on January 6
Stock News  ·  01-06
SSY Group (02005) Repurchases 1.5 Million Shares for HK$4.4694 Million on January 6
SSY Group Files HKEX Disclosure on Repurchase of 1.5 Million Shares for HKD 4.47 Million
Reuters  ·  01-06
SSY Group Files HKEX Disclosure on Repurchase of 1.5 Million Shares for HKD 4.47 Million
Zhitoing Hong Kong Stock Shareholder Equity Disclosures | January 6
Stock News  ·  01-06
Zhitoing Hong Kong Stock Shareholder Equity Disclosures | January 6
BRIEF-SSY Group Gets NMPA Approval For Drug Production And Registration For Perindopril Arginine And Amlodipine Besylate Tablets (III)
Reuters  ·  01-05
BRIEF-SSY Group Gets NMPA Approval For Drug Production And Registration For Perindopril Arginine And Amlodipine Besylate Tablets (III)
SSY Group Gets China Nod to Register Hypertension Drug
MT Newswires Live  ·  01-05
SSY Group Gets China Nod to Register Hypertension Drug
SSY Group (02005) Secures Drug Production Registration Approval for Perindopril Amlodipine Tablets (III)
Stock News  ·  01-05
SSY Group (02005) Secures Drug Production Registration Approval for Perindopril Amlodipine Tablets (III)
SSY Group - Obtained Approval for Drug Production and Registration for Perindopril Arginine and Amlodipine Besylate Tablets (Iii) From Nmpa
THOMSON REUTERS  ·  01-05
SSY Group - Obtained Approval for Drug Production and Registration for Perindopril Arginine and Amlodipine Besylate Tablets (Iii) From Nmpa
SSY Group (02005) Spends HK$3.1876 Million on Share Buyback of 1.1 Million Shares on January 5
Stock News  ·  01-05
SSY Group (02005) Spends HK$3.1876 Million on Share Buyback of 1.1 Million Shares on January 5
SSY Group Files HKEX Disclosure on Repurchase of 1.1 Million Shares at HKD 2.89–2.92
Reuters  ·  01-05
SSY Group Files HKEX Disclosure on Repurchase of 1.1 Million Shares at HKD 2.89–2.92
Zhitoong Hong Kong Stock Short Selling Statistics | January 5
Stock News  ·  01-05
Zhitoong Hong Kong Stock Short Selling Statistics | January 5
SSY Group's Sodium Glycerophosphate Injection Receives Chinese Regulatory Nod
MT Newswires Live  ·  2025-12-29
SSY Group's Sodium Glycerophosphate Injection Receives Chinese Regulatory Nod
SSY GROUP (02005) Secures Drug Production Registration Approval for Sodium Glycerophosphate Injection (10ml: 2.16g)
Stock News  ·  2025-12-29
SSY GROUP (02005) Secures Drug Production Registration Approval for Sodium Glycerophosphate Injection (10ml: 2.16g)
SSY Group Wins China Approval for Sodium Glycerophosphate Injection
Reuters  ·  2025-12-29
SSY Group Wins China Approval for Sodium Glycerophosphate Injection

Introduction

Company Name.
SSY GROUP
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Issue price:
--